Injection of triamcinolone acetonide into the posterior sub-tenon capsule for treatment of diabetic macular edema

Retina

Volumn 27, Issue 6, 2007, Pages 764-769

  Toda, Junko ^a   Fukushima, Harumi ^a   Kato, Satoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Diabetes; Macular edema; Steroid; Sub Tenon capsule; Triamcinolone acetonide

Indexed keywords

LEVOFLOXACIN; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE VARIABILITY; CATARACT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DISEASE EXACERBATION; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; HYPERGLYCEMIA; INJECTION; INTRAOCULAR PRESSURE ABNORMALITY; LENS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RETINA MACULA LUTEA; SIDE EFFECT; STUDENT T TEST; THICKNESS; TREATMENT OUTCOME;

AGED; DIABETIC RETINOPATHY; FASCIA; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULA LUTEA; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY;

EID: 34447339655     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318030bfcd     Document Type: Article

References (26)

1. Early Treatment of Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985;103:1796-1806.
2. Blankenship GW. Diabetic macular edema and argon laser photocoagulation. A prospective randomized study. Ophthalmology 1979;86:69-75.
3. McDonald HR, Schatz H. Grid photocoagulation of diffuse macular edema. Retina 1985;5:65-72.
4. Olk RJ. Modified grid argon (blue-green) laser photocoagulation for diffuse macular edema. Ophthalmology 1986;93:938-948.
5. Jonas JB, Söfker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001;132:425-427.
6. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920-927.
7. Jonas JB, Kreissig I, Söfker A, et al. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003;121:57-61.
8. Massin P, Audren F, Haouchine B, et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 2004;111:218-224.
9. Benz MS, Murray TG, Dubovy SR, et al. Endophthalmitis caused by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone. Arch Ophthalmol 2003;121:271-273.
10. Moshfeghi DM, Kaiser PK, Scott IU, et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003;136:791-796.
11. Ohguro N, Okada AA, Tano Y. Trans-Tenon's retrobulbar triamcinolone infusion for diffuse diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 2004;242:444-445.
12. Jennings T, Rusin MM, Tessler HH, et al. Posterior sub-Tenon injection of corticosteroids in uveitis patients with cystoid macular edema. Jpn J Ophthalmol 1988;32:385-391.
13. Tanner V, Kanski JJ, Frith PA. Posterior sub-Tenon triamcinolone injections in the treatment of uveitis. Eye 1998;12:679-685.
14. Dafflon ML, Tran VT, Guex-Closier Y, et al. Posterior sub-Tenon's steroid injections for the treatment of posterior ocular inflammation: indications, efficacy and side effects. Graefes Arch Clin Exp Ophthalmol 1999;237:289-295.
15. Thach AB, Dugel PU, Flindall RJ, et al. A comparison of retrobulbar versus sub Tenon's corticosteroid therapy for cystoid macular edema refractory to topical medications. Ophthalmology 1997;104:2003-2008.
16. Angunawela RI, Heatley CJ, Williamson TH, et al. Intravitreal triamcinolone acetonide for refractory uveitic cystoid macular oedema: long-term management and outcome. Acta Ophthalmol Scand 2005;83:595-599.
17. Bresnick GH. Diabetic macular edema: a review. Ophthalmology 1986;93:989-997.
18. Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type 2 diabetes over 6 years from diagnosis. Diabetologia 2001;44:156-163.
19. Herschler J. Increased intraocular pressure induced by repository corticosteroids. Am J Ophthalmol 1976;82:90-93.
20. Ferrante P, Ramsey A, Bunce C, et al. Clinical trial to compare efficacy and side-effects of injection of posterior sub-Tenon triamcinolone versus orbital floor methylprednisolone in the management of posterior uveitis. Clin Exp Ophthalmol 2004;32:563-567.
21. Yoshikawa K, Kotake S, Ichiishi A, et al. Posterior sub-Tenon injections of repository corticosteroids in uveitis patients with cystoid macular edema. Jpn J Ophthalmol 1995;39:71-76.
22. Oguro N. Steroid therapy for macular edema. Atarashii Ganka 2003;20:87-89.
23. Wilson CA, Berkowitz BA, Sato Y, et al. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 1992;110:1155-1159.
24. Beer PM, Bakri AJ, Singh RJ, et al. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 2003;110:681-686.
25. Inoue M, Takeda K, Morita K, et al. Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection. Am J Ophthalmol 2004;138:1046-1048.
26. Herschler J. Intractable intraocular hypertension induced by repository triamcinolone acetonide. Am J Ophthalmol 1972;74:501-504.